Trade Summary

4 months ago, AULT MILTON C III, serving as Dir at Alzamend Neuro, Inc. (ALZN), purchased 110,388 shares at $1.01 per share, for a total transaction value of $110,965.02. Following this transaction, AULT MILTON C III now holds 2,000 shares of ALZN.

The trade was executed on Tuesday, April 14, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 31, 2026 at 6:00 AM ET, 139 days after the trade was made.

Alzamend Neuro, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.